Blogs
The latest from the Proscia blog Digital pathology workflows depend on consistency, clarity, and confidence – especially as organizations scale studies, expand review teams, and incorporate AI-driven insights into everyday practice. Our...
Glencoe Software and CymaBay Therapeutics collaborated to digitally transform a pathology review workflow, which delivered on an NDA-enabling clinical trial requirement ahead of schedule. CymaBay Therapeutics, acquired by Gilead Sciences,...
The latest from the Proscia blog With the end of 2025 in sight, it’s only natural to ask what’s next, especially as digital pathology keeps advancing. Predictions are everywhere, and a lot of them are painfully obvious: adoption will...
From the blog at Indica Labs As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement. We are...
The latest from the blog at Indica Labs As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges...
From Techcyte: Join us for this Thought Leaders episode as Ben Cahoon, CEO of Techcyte, discusses how the company’s Fusion Platform is redefining digital pathology — bringing together anatomic and clinical pathology into a single,...
